Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism

Health Canada reviewed this issue because a published study found a link between SSRI exposure during pregnancy and an increased risk of autism in children. Autism is a developmental disability with lifelong impact. It affects a child's ability to communicate and interact with others.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 17:56 (UTC)
Created April 17, 2026, 17:56 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2017-05-18 00:00:00
open_canada_keywords {"fr": ["Examen sommaire de l'innocuité", "inhibiteurs sélectifs du recaptage de la sérotonine", "ISRS", "évaluation", "risque potentiel", "autisme", "exposition aux ISRS", "grossesse", "risque accru d'autisme", "autisme chez les enfants", "déficience intellectuelle", "impact à vie", "capacité d'un enfant"], "en": ["Summary Safety Review", "Selective-Serotonin-Reuptake Inhibitors", "SSRIs", "assessing", "potential risk", "Autism", "SSRI-exposure", "pregnancy", "increased risk-of autism", "autism in children", "developmental disability", "lifelong impact", "a child's ability"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Résumé de l'examen de l'innocuité - Inhibiteurs sélectifs du recaptage de la sérotonine (ISRS) - Évaluation du risque d'autisme
update_frequency as_needed